Home The Word Brain My Amedeo FAQ Privacy About


Amedeo Chinese

For Medical Students & Physicians

A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever.

Download the free PDF: Amedeo Chinese PDF

  Lung Cancer

  Free Subscription


17.08.2026

1 AJR Am J Roentgenol
1 Am J Clin Oncol
2 Am J Respir Cell Mol Biol
1 Ann Surg
4 Ann Surg Oncol
1 Cancer
3 Cancer Cell
1 Cancer Epidemiol Biomarkers Prev
1 Cancer Lett
2 Cancer Res
1 Cancer Sci
4 Chest
4 Clin Cancer Res
1 Clin Exp Metastasis
2 Clin Lung Cancer
1 Genes Chromosomes Cancer
2 Int J Radiat Oncol Biol Phys
1 J Clin Oncol
1 J Natl Cancer Inst
1 J Thorac Oncol
2 Lung Cancer
1 Mol Carcinog
1 Nat Med
1 Oncogene
1 Oncol Rep
1 Oncologist
1 PLoS One
1 Proc Natl Acad Sci U S A
1 Semin Oncol
1 Thorax


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    AJR Am J Roentgenol

  1. HWANG EJ, Lee T, Lim WH, Ko H, et al
    Artificial Intelligence-Assisted Lung Nodule Evaluation on Low-Dose Chest CT in Asymptomatic Individuals: A Prospective Randomized Controlled Trial.
    AJR Am J Roentgenol. 2026 Mar 18. doi: 10.2214/AJR.26.34552.
    PubMed         Abstract available


    Am J Clin Oncol

  2. MUSHEER A, Mannan MS, Khan MW, Junaid A, et al
    Durvalumab Consolidation After Chemoradiotherapy in Unresectable Stage III Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis of Efficacy and Safety.
    Am J Clin Oncol. 2026 Aug 10. doi: 10.1097/COC.0000000000001361.
    PubMed         Abstract available


    Am J Respir Cell Mol Biol

  3. CALYECA J, Thannickal VJ
    A post-translational rheostat of TGF-beta signaling controlling lung cancer metastasis.
    Am J Respir Cell Mol Biol. 2026 Aug 11:aanag161. doi: 10.1093.
    PubMed        

  4. LI Y, Zhou Y, Zhao P, Shi M, et al
    ZDHHC11-Mediated Palmitoylation of PPM1A Regulates Lung Cancer Metastasis via the TGF-beta1-Smad2/3 Signaling Pathway.
    Am J Respir Cell Mol Biol. 2026 Aug 10:aanag156. doi: 10.1093.
    PubMed         Abstract available


    Ann Surg

  5. HOLMES HM, McGann KC, Chen SC, Welch C, et al
    Combining Commercial Cancer Protein Biomarkers and Benign Fungal Antibodies Improves Diagnostic Accuracy in Pulmonary Nodules.
    Ann Surg. 2026;284:638-646.
    PubMed         Abstract available


    Ann Surg Oncol

  6. QI YF, Qiu ZB, Huang WY, Zhang C, et al
    ASO Visual Abstract: The Role of PD-L1 in Treatment Decision-Making for Perioperative EGFR-Mutated Lung Cancer and Its Genomic Analysis.
    Ann Surg Oncol. 2026 Aug 11. doi: 10.1245/s10434-026-19871.
    PubMed        

  7. TAKADA K, Koga T, Nomura K, Matsubara T, et al
    Oncological Outcomes of Segmentectomy for Centrally Located Small-Sized Non-small-cell Lung Cancer: A Multicenter Study (CReGYT-02 Study).
    Ann Surg Oncol. 2026 Aug 10. doi: 10.1245/s10434-026-20379.
    PubMed         Abstract available

  8. MAEKAWA A, Perri G, Heo D, Cemin G, et al
    Treatment Strategies and Outcomes for Single-Site Recurrent Pancreatic Ductal Adenocarcinoma After Curative-Intent Surgery: Local Therapies are Associated with Longer Survival in Selected Cases: A Systematic Review and Meta-analysis.
    Ann Surg Oncol. 2026;33:8438-8447.
    PubMed         Abstract available

  9. AIYAMA T, Kakisaka T, Shichi S, Sakamoto Y, et al
    Multiplication of Alpha-Fetoprotein and Protein Induced by Vitamin K Absence-II is Associated with Prognosis After Pulmonary Metastasectomy in Hepatocellular Carcinoma.
    Ann Surg Oncol. 2026;33:7842-7848.
    PubMed         Abstract available


    Cancer

  10. SULLIVAN DC, McNitt-Gray M, Aberle DR, Avila RS, et al
    The American Cancer Society National Lung Cancer Roundtable strategic plan: Opportunities in advanced imaging across the lung cancer care continuum.
    Cancer. 2026;132:e70516.
    PubMed         Abstract available


    Cancer Cell

  11. LI ZM, Zhou Z, He ZY, Han L, et al
    SYS6010, epidermal growth factor receptor-targeting antibody-drug conjugate for advanced non-small cell lung cancer: A phase 1 trial.
    Cancer Cell. 2026 Aug 13:S1535-6108(26)00350-8. doi: 10.1016/j.ccell.2026.
    PubMed         Abstract available

  12. YEO HTG, Tan IB
    Mapping micrometastatic seeds of relapse.
    Cancer Cell. 2026;44:1539-1541.
    PubMed         Abstract available

  13. LIU Y, Jadhav AS, Pan Y, Liao J, et al
    Spatial multi-omics landscape of colorectal cancer macro- and micrometastases.
    Cancer Cell. 2026;44:1568-1586.
    PubMed         Abstract available


    Cancer Epidemiol Biomarkers Prev

  14. DESHMUKH MS, Lawrence KG, Sandler DP, O'Brien KM, et al
    Personal Talc Use and Incident Lung Cancer.
    Cancer Epidemiol Biomarkers Prev. 2026.
    PubMed         Abstract available


    Cancer Lett

  15. CHEN Z, Tan J, Peng X
    Letter to the Editor: Comment on "Immunotherapy-based combination remodels the immunosuppressive microenvironment and enhances efficacy in advanced SMARCA4-deficient non-small cell lung cancer".
    Cancer Lett. 2026 Aug 13:218778. doi: 10.1016/j.canlet.2026.218778.
    PubMed        


    Cancer Res

  16. GARCIA BORREGO S, Misale S
    KRASG12V Degraders Provide a Potential Therapeutic Opportunity in Lung Adenocarcinoma.
    Cancer Res. 2026;86:3903-3905.
    PubMed         Abstract available

  17. MARTIN A, Garcia-Perez IM, San Jose S, Rojo P, et al
    Targeted KRASG12V Degradation In Vivo Elicits Lung Adenocarcinoma Regression with Subsequent Relapse from Dysregulated Proteolysis.
    Cancer Res. 2026;86:4115-4135.
    PubMed         Abstract available


    Cancer Sci

  18. ZHAO Y, Liu Y, Xie M, Ye Z, et al
    Mitochondrial Morphology Dynamics Remodel Metabolism and Affect TKI Sensitivity in EGFR-Mutated Lung Cancer.
    Cancer Sci. 2026 Aug 13:10.1111/cas.70488. doi: 10.1111/cas.70488.
    PubMed         Abstract available


    Chest

  19. ABDO M, Pott H, Reck M, Martin R, et al
    Integrating Quantitative CT Biomarkers to Enhance COPD Detection in the HANSE Lung Cancer Screening Program.
    Chest. 2026 Aug 14:S0012-3692(26)06346-4. doi: 10.1016/j.chest.2026.07.5237.
    PubMed         Abstract available

  20. CHENG Y, Chen X, Zhu L, Xiang J, et al
    From Hazy Opacity to Cystic Nodule: An Atypical Radiologic Course of Pulmonary Metastasis From Colorectal Carcinoma.
    Chest. 2026;170:e53-e57.
    PubMed         Abstract available

  21. AYDIN Y, Ogul H, Cakir M
    A 19-Year-Old Woman With Pulmonary and Vertebral Lesions Suggestive of Metastatic Hepatocellular Carcinoma.
    Chest. 2026;170:e23-e27.
    PubMed         Abstract available

  22. PATEL P, Ost DE, Shaller B, Chang J, et al
    Cone Beam CT Imaging-Guided Bronchoscopy vs CT Imaging-Guided Transthoracic Needle Biopsy for Peripheral Pulmonary Lesion Diagnosis.
    Chest. 2026;170:604-618.
    PubMed         Abstract available


    Clin Cancer Res

  23. ROHRBERG KS, Brandao M, Castanon Alvarez E, Felip E, et al
    Rilvegostomig for Metastatic Non-Small-Cell Lung Cancer: A First-In-Human Phase I/II Clinical Study.
    Clin Cancer Res. 2026 Aug 10. doi: 10.1158/1078-0432.CCR-26-0333.
    PubMed         Abstract available

  24. ZENG J, Cui S, Hippe DS, Fu J, et al
    Mature Outcomes and Patterns of Failure in the Phase II FLARE-RT Trial of Biological Image-Guided and Risk-Adaptive Chemoradiation for Unresectable NSCLC.
    Clin Cancer Res. 2026;32:3434-3443.
    PubMed         Abstract available

  25. GARIAZZO E, Elkrief A, Concannon K, Ognissanti D, et al
    Clinical Outcomes and Predictors of Response to PD-(L)1 Blockade in Patients with NSCLC without Actionable Genomic Alterations Who Never Used Tobacco.
    Clin Cancer Res. 2026;32:3683-3693.
    PubMed         Abstract available

  26. GUO Q, Deng C, Pan X, Liu J, et al
    A Noninvasive Circulating Tumor DNA Methylation Classifier to Identify Benign Pulmonary Nodules.
    Clin Cancer Res. 2026;32:3629-3640.
    PubMed         Abstract available


    Clin Exp Metastasis

  27. ZHOU J, Zhang S, Xu Y, Ye W, et al
    Correction: Cullin 3 overexpression inhibits lung cancer metastasis and is associated with survival of lung adenocarcinoma.
    Clin Exp Metastasis. 2026;43:40.
    PubMed        


    Clin Lung Cancer

  28. HA G, Vimolratana M, Chudgar NP, Stiles BM, et al
    Brief Report on Sociodemographic Patterns of Lung Cancer in Individuals Who Never Smoked.
    Clin Lung Cancer. 2026;27:108-112.
    PubMed         Abstract available

  29. CANASLAN K, Primdahl D, Iams W, Lugo C, et al
    Immunotherapy in Patients With Small-Cell Lung Cancer and Lambert-Eaton Myasthenic Syndrome: A Multi-institutional Case Series.
    Clin Lung Cancer. 2026;27:113-117.
    PubMed        


    Genes Chromosomes Cancer

  30. ZHANG X, Zhou H, Li Y, Chu Y, et al
    The Contribution of CD133 Gene Polymorphisms to Cancer Risk: Integrating Case-Control Evidence With Meta-Analysis.
    Genes Chromosomes Cancer. 2026;65:e70162.
    PubMed         Abstract available


    Int J Radiat Oncol Biol Phys

  31. WANG S, Zhao F, Wang J, Hua Y, et al
    Prophylactic Recombinant Human Thrombopoietin Prevents Cancer Therapy-Induced Thrombocytopenia During Concurrent Chemoradiation Therapy in Limited-Stage Small Cell Lung Cancer: A Prospective, Multicenter, Phase II Clinical Trial.
    Int J Radiat Oncol Biol Phys. 2026;126:147-155.
    PubMed         Abstract available

  32. LU Y, Chen J, Sheng Y, Wang W, et al
    Comparing Different Planning Strategies for Pencil Beam Scanning Carbon Ion Radiotherapy for Stage I Peripheral Non-Small Lung Cancer: Toward Optimized Clinical Decision-Making.
    Int J Radiat Oncol Biol Phys. 2026 Aug 13:S0360-3016(26)04161.
    PubMed         Abstract available


    J Clin Oncol

  33. PIOTROWSKA Z, Shao-Weng Tan D, Smit EF, Spira AI, et al
    Erratum: Safety, Tolerability, and Antitumor Activity of Zipalertinib Among Patients With Non-Small-Cell Lung Cancer Harboring Epidermal Growth Factor Receptor Exon 20 Insertions.
    J Clin Oncol. 2026 Aug 14:JCO2601931. doi: 10.1200/JCO-26-01931.
    PubMed        


    J Natl Cancer Inst

  34. O'RORKE MA, Xu T, DeCook RR, McDowell BD, et al
    Quality of life and care experiences in a US multi-institutional neuroendocrine tumor cohort.
    J Natl Cancer Inst. 2026;118:1403-1415.
    PubMed         Abstract available


    J Thorac Oncol

  35. YATABE Y, Beasley MB, Borczuk A, Berezowska S, et al
    Prognostic Significance of Spread Through Airspaces (STAS) in Stage Ia/bN0 Non-small Cell Lung Cancer - An Evaluation in the JCOG0802/WJOG4607L Clinical Trial Patients.
    J Thorac Oncol. 2026 Aug 14:104156. doi: 10.1016/j.jtho.2026.104156.
    PubMed         Abstract available


    Lung Cancer

  36. NUAMEK T, Liao K, Ward A, Devaraj RL, et al
    Real-world evaluation of the christie symptom inventory-lung cancer (CSI-lung) electronic patient-reported outcome measure: validity, reliability, responsiveness, and patient experiences.
    Lung Cancer. 2026;220:109564.
    PubMed         Abstract available

  37. BURZIC A, Baldwin DR, McKeever TM, O'Dowd EL, et al
    Structured triage of incidental findings in lung cancer screening: Outcomes from a UK programme.
    Lung Cancer. 2026;220:109565.
    PubMed         Abstract available


    Mol Carcinog

  38. WANG Z, Qiu X, Liu P, Li Y, et al
    Association of Expression of YTH-Domain Family Protein 3 (YTHDF3) With Brain Metastases and Unfavorable Survival in Patients With Stage IV Lung Adenocarcinoma.
    Mol Carcinog. 2026;65:1043-1051.
    PubMed         Abstract available


    Nat Med

  39. TIAN R, Zong X, Ren D, Tica S, et al
    Biological aging and generational shifts in early-onset cancer risk.
    Nat Med. 2026;32:2983-2990.
    PubMed         Abstract available


    Oncogene

  40. MORINAGA T, Hayama S, Nakamura Y, Kawase K, et al
    A truncated TNS3 isoform expressed in metastatic triple negative breast cancer stabilizes FAK and promotes lung metastasis.
    Oncogene. 2026 Jul 10. doi: 10.1038/s41388-026-03894.
    PubMed         Abstract available


    Oncol Rep

  41. XU S, Chang X, Wu X, Wang F, et al
    HDAC1 promotes lung adenocarcinoma progression via the nuclear accumulation of beta?catenin.
    Oncol Rep. 2026;56:169.
    PubMed         Abstract available


    Oncologist

  42. EL ZARIF T, Abou Alaiwi S, Nassar AH, Gariazzo E, et al
    Effectiveness and safety of immunotherapy in advanced NSCLC with pericardial effusions: a global retrospective multicenter study.
    Oncologist. 2026;31:oyag277.
    PubMed         Abstract available


    PLoS One

  43. WANG X, Tang F, Qin J, Xiao T, et al
    Regulatory effects of smoking cessation on the cellular microenvironment and differentially expressed genes in precancerous lesions of pulmonary nodules in mice based on single-cell RNA sequencing and immune repertoire-sequencing.
    PLoS One. 2026;21:e0356148.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  44. DU H, Lang T, Zha X, Qu C, et al
    Single-cell multiomics identifies an ALDH9A1-carnitine signaling axis driving resistance of NSCLC to immunotherapy.
    Proc Natl Acad Sci U S A. 2026;123:e2535328123.
    PubMed         Abstract available


    Semin Oncol

  45. AIBANI R, Collins J, Borna AK, Kamran A, et al
    Erratum to 'Comparative efficacy of osimertinib with and without radiation therapy in EGFR-mutated nonsmall cell lung cancer with brain metastases' [Seminars in Oncology 53/1 (2026) 152436].
    Semin Oncol. 2026 Aug 12:152524. doi: 10.1016/j.seminoncol.2026.152524.
    PubMed        


    Thorax

  46. MULLIN ML, Verghese P, Khaw CR, Creamer A, et al
    Upstaging of screen-detected lung cancers during diagnostic assessment.
    Thorax. 2026;81:894-902.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Lung Cancer is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum